BDBM320318 2-{5-[(3-Fluoropyridin-2-yl)(oxan-4-yl)methyl]-6-methanesulfonyl-3-[4-(2H3)methyl-1-methyl-1H-1,2,3-triazol-5-yl]-5H-pyrido[3,2-b]indol-9-yl}-1λ6,2-thiazolidine-1,1-dione::US10174024, Example 35::US10174024, Example 36
SMILES: Cc1[nH]nn(C)c1-c1cnc2c(c1)n(C(C1CCOCC1)c1ncccc1F)c1c(ccc(N3CCCS3(=O)=O)c21)S(C)(=O)=O
InChI Key: InChIKey=RTZAWQZDUBTVBH-UHFFFAOYSA-N
Data: 2 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM320318 (2-{5-[(3-Fluoropyridin-2-yl)(oxan-4-yl)methyl]-6-m...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The binding of compounds to bromodomain BRD4 (44-168), BRD4 (333-460), and BRD4 (1-477 or 44-460) was assessed using a time resolved fluorescent reso... | US Patent US10174024 (2019) BindingDB Entry DOI: 10.7270/Q2319XZ1 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM320318 (2-{5-[(3-Fluoropyridin-2-yl)(oxan-4-yl)methyl]-6-m...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The binding of compounds to bromodomain BRD4 (44-168), BRD4 (333-460), and BRD4 (1-477 or 44-460) was assessed using a time resolved fluorescent reso... | US Patent US10174024 (2019) BindingDB Entry DOI: 10.7270/Q2319XZ1 | |||||||||||
More data for this Ligand-Target Pair |